Genocea Biosciences
GNCA
$0.0001000
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)
Categories
Genocea Biosciences (GNCA) - Net assets
Net assets on the balance sheet as of March 2022 : $12.38 M
According to Genocea Biosciences
's latest financial reports the company has $12.38 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Genocea Biosciences - Net assets on balance sheet (from 2012 to 2022)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2021-12-31 | $27.07 M | 201.44% |
| 2020-12-31 | $8.98 M | -64.13% |
| 2019-12-31 | $25.04 M | 241.4% |
| 2018-12-31 | $7.33 M | -221.24% |
| 2017-12-31 | $-6.05 M | -113.28% |
| 2016-12-31 | $45.54 M | -49.21% |
| 2015-12-31 | $89.66 M | 175.82% |
| 2014-12-31 | $32.5 M | 2171.63% |
| 2013-12-31 | $1.43 M | -77.3% |
| 2012-12-31 | $6.3 M | 47.11% |
| 2011-12-31 | $4.28 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $89.28 B | 720,836.62% | 🇺🇸 USA |
 Merck MRK | $37.63 B | 303,775.66% | 🇺🇸 USA |
 Novavax NVAX | -$0.72 B | -5,888.67% | 🇺🇸 USA |
 Agenus
AGEN | -$0.15 B | -1,298.08% | 🇺🇸 USA |
 iBio IBIO | $9.19 M | -25.74% | 🇺🇸 USA |